3[2]Mortarelli E A.Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer[J].Ann Clin Lab Sci,1992,22(4):201-203.
5[7]Thompson I M,Pauler D K,Goodman P J,et al.Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter[J].N Engl J Med,2004,350 (22):2239-2246.
6[9]Carter H B.Prostate cancers in men with low PSA leves-must we find them?[J].N Eng1 J Med,2004,350(22):2292-2294.
7[10]D'Amico A V.Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy[J].N Eng1 J Med,2004,351 (2):125-135.
9Horguchi A, Nakashima J, Nakagawa K, et al. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer[J]. Prostate,2003,56(1):23-29.
10Lujan M, Paez A, Llanes L, et al. Prostate specific antigen density. Is there a role for this parameter when screening for prostate cancer? [J].Prostate Cancer Prostatic Dis,2001,4(3):146-149.
